Assuming potential is required, the following results were found.

  • UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

    for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease. A team led by Roberta Diaz Brinton, PhD, director of the Center for...

    https://mschristian.org/index.php/articles/2-uncategorised/8466-ua-receives-37-5-million-nih-grant-to-research-potential-regenerative-therapy-for-alzheimer-s
  • Newly discovered leukodystrophy in children: Potential cure

    Cite This Page: IDIBELL-Bellvitge Biomedical Research Institute. "Newly discovered leukodystrophy in children: Potential cure: The gene that causes the disease is called DEGS1 and its defect may be counteracted with fingolimod." ScienceDaily....

    https://mschristian.org/index.php/articles/2-uncategorised/5007-newly-discovered-leukodystrophy-in-children-potential-cure
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    the biological processes in a way that is not possible on Earth. This innovative approach to modelling disease has the potential to provide valuable new insight into the fundamental mechanisms underlying neurodegenerative disorders that may accelerate...

    https://mschristian.org/index.php/blog/first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • Trinity researchers in potential MS treatment breakthrough - The Irish Times

    the damage, they believe Their work, published in Immunity scientific journal, also suggested there is significant potential in drugs that target the IL-17 molecule, both for MS and psoriasis/rheumatoid arthritis. MS is a debilitating disease that...

    https://mschristian.org/index.php/articles/2-uncategorised/9957-trinity-researchers-in-potential-ms-treatment-breakthrough-the-irish-times
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    Biogen in-licensed worldwide commercialization rights to Alkermes’ ALKS Vumerity (BIIB098), which the company claims has a potentially differentiated profile to Tecfidera. The NDA for Vumerity is under review in the United States with the FDA decision...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Multiple Doses of Stem Cells Show Potential in Treating Severe Asthma - Yahoo Finance

    be borne in mind for future clinical trials in patients with severe asthma." "Outcomes from this study highlight the potential of mesenchymal stromal cells to reduce lung inflammation caused by asthma, which affects more than 25 million people in...

    https://mschristian.org/index.php/articles/2-uncategorised/9320-multiple-doses-of-stem-cells-show-potential-in-treating-severe-asthma-yahoo-finance
  • Potential genetic markers of multiple sclerosis severity

    for Multiple Sclerosis. "We believe that our study opens up a new line of investigation targeting complement genes as a potential way to treat disease progression and nerve cell death." For their study, the researchers used optical coherence tomography...

    https://mschristian.org/index.php/articles/2-uncategorised/9196-potential-genetic-markers-of-multiple-sclerosis-severity
  • Antibodies against Imood could be potential treatment for OCD

    the researchers to file a patent application for the antibody and they are now working with a drug company to develop a potential treatment for human patients. There is mounting evidence that the immune system plays an important role in mental...

    https://mschristian.org/index.php/articles/2-uncategorised/10612-antibodies-against-imood-could-be-potential-treatment-for-ocd
  • UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

    for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease. A team led by Roberta Diaz Brinton, PhD, director of the Center for...

    https://mschristian.org/index.php/blog/ua-receives-37-5-million-nih-grant-to-research-potential-regenerative-therapy-for-alzheimer-s
  • Essential Oils: A Potential Way to Ease MS Stress

    By Brian P. Dunleavy Medically Reviewed by Samuel Mackenzie, MD, PhD Last Updated: October 31, 2019 Do essential oils have a role in the treatment of MS? Maybe. While they haven’t yet been studied specifically in this population, they have been shown...

    https://mschristian.org/index.php/articles/2-uncategorised/9200-essential-oils-a-potential-way-to-ease-ms-stress
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    on coronavirus treatment and prevention. While any success there would be a plus, my attention is on products with more potential for long-term growth. Sanofi must find ways to compensate for declines in older blockbuster drugs. Diabetes drug Lantus is...

    https://mschristian.org/index.php/blog/my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool
  • Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis.

    disability and neurological defects. A viable target for treating MS appears to be the Transient Receptor Potential Ankyrin 1 (TRPA1) calcium channel, whose inhibition has been shown to have beneficial effects on neuroglial cells and protect against...

    https://mschristian.org/index.php/blog/computational-drug-repurposing-algorithm-targeting-trpa1-calcium-channel-as-a-potential-therapeutic-solution-for-multiple-sclerosis
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    the biological processes in a way that is not possible on Earth. This innovative approach to modelling disease has the potential to provide valuable new insight into the fundamental mechanisms underlying neurodegenerative disorders that may accelerate...

    https://mschristian.org/index.php/articles/2-uncategorised/9425-first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    placebo-controlled Phase 1b part of this study. “We are encouraged by the safety profile and early findings of potential efficacy for people living with progressive MS, as shown in our Phase 1a study data presented at ECTRIMS in September,” said AJ...

    https://mschristian.org/index.php/blog/atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace
  • NIH trial aims to improve drug discovery for ischemic stroke

    during human testing. Seven laboratories will collaborate to apply the robust practices when testing the efficacy of six potential therapies for ischemic brain injury. An estimated $4 million will be provided by the NIH over the course of three years....

    https://mschristian.org/index.php/blog/nih-trial-aims-to-improve-drug-discovery-for-ischemic-stroke
  • Trinity researchers in potential MS treatment breakthrough - The Irish Times

    the damage, they believe Their work, published in Immunity scientific journal, also suggested there is significant potential in drugs that target the IL-17 molecule, both for MS and psoriasis/rheumatoid arthritis. MS is a debilitating disease that...

    https://mschristian.org/index.php/blog/trinity-researchers-in-potential-ms-treatment-breakthrough-the-irish-times
  • Newly discovered leukodystrophy in children: Potential cure

    Cite This Page: IDIBELL-Bellvitge Biomedical Research Institute. "Newly discovered leukodystrophy in children: Potential cure: The gene that causes the disease is called DEGS1 and its defect may be counteracted with fingolimod." ScienceDaily....

    https://mschristian.org/index.php/blog/newly-discovered-leukodystrophy-in-children-potential-cure
  • Atara Biotherapeutics Announces Third Quarter 2019 Financial Results and Recent Clinical, Operational and Strategic Progress - BioSpace

    placebo-controlled Phase 1b part of this study. “We are encouraged by the safety profile and early findings of potential efficacy for people living with progressive MS, as shown in our Phase 1a study data presented at ECTRIMS in September,” said AJ...

    https://mschristian.org/index.php/articles/2-uncategorised/9192-atara-biotherapeutics-announces-third-quarter-2019-financial-results-and-recent-clinical-operational-and-strategic-progress-biospace
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    Biogen in-licensed worldwide commercialization rights to Alkermes’ ALKS Vumerity (BIIB098), which the company claims has a potentially differentiated profile to Tecfidera. The NDA for Vumerity is under review in the United States with the FDA decision...

    https://mschristian.org/index.php/articles/2-uncategorised/8852-biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • My Top 3 Drug Stocks to Buy in the Market Crash - The Motley Fool

    on coronavirus treatment and prevention. While any success there would be a plus, my attention is on products with more potential for long-term growth. Sanofi must find ways to compensate for declines in older blockbuster drugs. Diabetes drug Lantus is...

    https://mschristian.org/index.php/articles/2-uncategorised/10427-my-top-3-drug-stocks-to-buy-in-the-market-crash-the-motley-fool

Results 1 - 20 of 250